![PE142000: α-GalNAc-PEG4-Acid label-new 2-[2-(2-Azidoethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-β-D-galactopyranoside](https://cdn.shopify.com/s/files/1/0810/4889/5786/files/PE142000-R_e0a7469d-edbc-4282-87d4-86a6ff3d3063.svg?v=1700577213)
Pay in 4 interest-free payments of $43.75 Learn more
Ships within 48 hours · Estimated delivery Sep 10 - Sep 15
2-[2-(2-Azidoethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-β-D-galactopyranoside
HCl / N-[2-Butyl-3-[4-[3-(butylamino)propoxybenzoyl]-5-benzofuranyl]-methanesulfonamide-d6 Hydrochloride
or to dibenzocyclooctyne (DBCO) and related strained alkynes via copper-free click chemistry
36 / A β-D-N-acetylgalactosamine (GalNAcβ) ligand equipped with an amine-functionalized linker through a pentyl spacer
PE142000: α-GalNAc-PEG4-Acid label-new 2-[2-(2-Azidoethoxy)ethoxy]ethyl 2-acetamido-2-deoxy-β-D-galactopyranosideC17H31NO11 425. 43 An D N acetylgalactosamine (GalNAc) ligand equipped with a terminal carboxylic acid through a hydrophilic PEG4 spacer. The carboxylic acid can be activated to NHS, sulfo NHS, or pentafluorophenyl esters and reacted with amine functionalized platforms or lysine residues on proteins and peptides to form amide bonds. This compound enables the construction of hepatocyte targeted therapeutics and research tools that exploit the
